Search results with tag "Cell lymphoma"
Japanese classification of gastric carcinoma: 3rd English ...
www.jgca.jpLymphoma B-cell lymphoma MALT (mucosa-associated lymphoid tissue) lymphoma 9699/3 Follicular lymphoma 9690/3 Mantle cell lymphoma 9673/3 Diffuse large B-cell lymphoma 9680/3 Other B-cell lymphomas T-cell lymphoma Other lymphomas Metastatic tumor Tumor-like lesion Hyperplastic polyp Fundic gland polyp Heterotopic submucosal gland Heterotopic ...
NCCN Guidelines for Patients Diffuse Large B-Cell Lymphoma
www.nccn.orgDiffuse Large B-Cell Lymphoma, 2020 1 DLBCL basics The lymph systemThe lymph system | Types of lymphoma Diffuse large B-cell lymphoma (DLBCL) is a type of cancer called non-Hodgkin lymphoma. It is a fast-growing cancer, but with the right treatment, it can be well controlled. The lymph system Lymphoma is a cancer of the lymph (or lymphatic) system.
NCCN Guidelines for Patients Mantle Cell Lymphoma
www.nccn.orgMantle cell lymphoma (MCL) is a cancer that develops from lymphocytes in the lymph system. Lymphomas are cancers of lymphocytes within the lymph system. experience these feelings, and The lymph system transports fluids to the bloodstream and helps kill germs in the body.
Minimal Residual Disease (MRD) - Leukemia & Lymphoma …
www.lls.orgLymphoma • MRD is detected through flow cytometry and PCR. • MRD testing is used in follicular, mantle cell and diffuse large B-cell lymphoma (DLBCL). • MRD testing helps detect patients who are at risk of relapsing. These patients can then receive additional treatment.
BC Cancer Protocol Summary for Treatment of Lymphoma …
www.bccancer.bc.camantle cell lymphoma ... Patients with paranasal sinus involvement with large cell lymphoma who have a complete response at the completion of their chemotherapy should receive intrathecal methotrexate 12 mg alternating with intrathecal cytarabine 50 mg twice weekly x 6 doses (3 doses of each over 3 weeks) starting in week 18. ...
MULTIPLE MYELOMA (MM) - Celgene
media.celgene.comArea of Research Phase 1 Phase 2 Phase 3 Post-Approval Research C C F P- esear C- C- T T appr LYMPHOMA REVLIMID® (lenalidomide) Mantle cell lymphoma: Relapsed/refractory . . . . . . . . . . Diffuse large B-cell lymphoma (ABC subtype): First-line .
Lymphoma
www.albertahealthservices.caNodular lymphocyte predominant Hodgkin Lymphoma . Mantle cell (can be aggressive) Mycosis fungoides /Sezary syndrome . Primary cutaneous, CD30+ Primary cutaneous perioheral T-cell lymphoma PTCL, CD30- T-cell large granular lymphocytic leukemia . Aggressive Diffuse large B-cell o T-cell/histocyte-rich DLBCL o Primary DLBCL of the CNS